ARCHIVES

NCI Presents More Evidence f Program Accomplishments; Candlelighters Call For New Pediatric Effort, Including Regional Centers

This article is from The Cancer Letter archive.

Vol. 05 No. 14 | April 6, 1979

Download PDF Visit The Full Archive

Related Articles

Increase Cancer Center Grants More Than R01s, SPOREs, Report Tells NCI

February 28, 2003

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

Cancer Act Renewal Nears Vote By House

August 11, 1978

CMF Studies Show Higher Recurrence for Post-Menopausal Patients – Caldwell

November 12, 1976

Study: Ibrutinib Lowers IgM, Bone Marrow Disease Burden

July 26, 2013

Treatment Progress Since 1972 Provides Powerful Support For Continuing National Cancer Program

March 23, 1979